Denis Burkitt and the African Lymphoma

Overview

Journal Ecancermedicalscience

Specialty Oncology

Date 2012 Jan 26

PMID 22276020

Citations 4

Authors

I Magrath

Affiliations

Soon will be listed here.

Abstract

Burkitt lymphoma has provided a model for the understanding of the epidemiology, the molecular abnormalities that induce tumours, and the treatment of other lymphomas. It is important to remember that the early phases of this work were conducted in Africa where today, unfortunately, the disease usually results in death because of limited resources, even though most children in more developed countries are cured. This must be changed. In addition, it is time to re-explore, with modern techniques, some of the questions that were raised some 50 years ago shortly after Burkitt's first description, as well as new questions that can be asked only in the light of modern understanding of the immune system and the molecular basis of tumor development. The African lymphoma has taught us much, but there is a great deal still to be learned.

Citing Articles

Assessment of Treatment Outcomes and Associated Factors Among Pediatric Patients With Burkitt Lymphoma at Kenyatta National Hospital.

Toor D, Degu A, Karimi P Cancer Rep (Hoboken). 2025; 8(1):e70112.

PMID: 39806864 PMC: 11729749. DOI: 10.1002/cnr2.70112.

Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection.

Maroui M, Odongo G, Mundo L, Manara F, Mure F, Fusil F Proc Natl Acad Sci U S A. 2024; 121(16):e2314426121.

PMID: 38574017 PMC: 11032484. DOI: 10.1073/pnas.2314426121.

Spatial distribution of incident pediatric Burkitt lymphoma in central and northern Malawi and association with malaria prevalence.

Gondwe Y, Salima A, Manda A, Ozuah N, Mapurisa G, Brandt K Pediatr Blood Cancer. 2022; 69(10):e29867.

PMID: 35731580 PMC: 10846644. DOI: 10.1002/pbc.29867.

Epigenetic Alteration of the Cancer-Related Gene TGFBI in B Cells Infected with Epstein-Barr Virus and Exposed to Aflatoxin B1: Potential Role in Burkitt Lymphoma Development.

Manara F, Jay A, Odongo G, Mure F, Maroui M, Diederichs A Cancers (Basel). 2022; 14(5).

PMID: 35267594 PMC: 8909323. DOI: 10.3390/cancers14051284.

Bilateral jaws involvement of Burkitt's lymphoma in a pediatric patient.

de Freitas Filho S, Moura L, de Souza M, Rubira C, Oliveira D J Clin Exp Dent. 2021; 13(3):e323-e327.

PMID: 33680336 PMC: 7920559. DOI: 10.4317/jced.57740.

References

Magrath I . Lessons from clinical trials in African Burkitt lymphoma. Curr Opin Oncol. 2009; 21(5):462-8. DOI: 10.1097/CCO.0b013e32832f3dcd. View

Dang C, ODonnell K, Juopperi T . The great MYC escape in tumorigenesis. Cancer Cell. 2005; 8(3):177-8. DOI: 10.1016/j.ccr.2005.08.005. View

. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. IARC Monogr Eval Carcinog Risks Hum. 1997; 70:1-492. PMC: 5046075. View

DALLDORF G, LINSELL C, Barnhart F, Martyn R . AN EPIDEMIOLOGIC APPROACH TO THE LYMPHOMAS OF AFRICAN CHILDREN AND BURKITT'S SACROMA OF THE JAWS. Perspect Biol Med. 1964; 7:435-49. DOI: 10.1353/pbm.1964.0023. View

ZECH L, Haglund U, Nilsson K, Klein G . Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer. 1976; 17(1):47-56. DOI: 10.1002/ijc.2910170108. View

Boerma E, Siebert R, Kluin P, Baudis M . Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge. Leukemia. 2008; 23(2):225-34. DOI: 10.1038/leu.2008.281. View

Gunapala D, Facer C, Davidson R, Weir W . In vitro analysis of Epstein-Barr virus: host balance in patients with acute Plasmodium falciparum malaria. I. Defective T-cell control. Parasitol Res. 1990; 76(6):531-5. DOI: 10.1007/BF00931060. View

Magrath I . African Burkitt's lymphoma. History, biology, clinical features, and treatment. Am J Pediatr Hematol Oncol. 1991; 13(2):222-46. View

Wright D . Burkitt's tumour in England. A comparison with childhood lymphosarcoma. Int J Cancer. 1966; 1(5):503-14. DOI: 10.1002/ijc.2910010510. View

10.

Geser A, Brubaker G, Draper C . Effect of a malaria suppression program on the incidence of African Burkitt's lymphoma. Am J Epidemiol. 1989; 129(4):740-52. DOI: 10.1093/oxfordjournals.aje.a115189. View

11.

Morrow R, Kisuule A, Pike M, Smith P . Burkitt's lymphoma in the Mengo Districts of Uganda: epidemiologic features and their relationship to malaria. J Natl Cancer Inst. 1976; 56(3):479-83. DOI: 10.1093/jnci/56.3.479. View

12.

Ruf I, Rhyne P, Yang H, Borza C, Hutt-Fletcher L, Cleveland J . EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma. Curr Top Microbiol Immunol. 2001; 258:153-60. DOI: 10.1007/978-3-642-56515-1_10. View

13.

Whittle H, Brown J, Marsh K, Greenwood B, Seidelin P, Tighe H . T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature. 1984; 312(5993):449-50. DOI: 10.1038/312449a0. View

14.

Yustein J, Dang C . Biology and treatment of Burkitt's lymphoma. Curr Opin Hematol. 2007; 14(4):375-81. DOI: 10.1097/MOH.0b013e3281bccdee. View

15.

Carpenter L, Newton R, Casabonne D, Ziegler J, Mbulaiteye S, Mbidde E . Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda. Int J Cancer. 2007; 122(6):1319-23. DOI: 10.1002/ijc.23254. View

16.

DORFMAN R . CHILDHOOD LYMPHOSARCOMA IN ST. LOUIS, MISSOURI, CLINICALLY AND HISTOLOGICALLY RESEMBLING BURKITT'S TUMOR. Cancer. 1965; 18:418-30. DOI: 10.1002/1097-0142(196504)18:4<418::aid-cncr2820180404>3.0.co;2-i. View

17.

Rainey J, Mwanda W, Wairiumu P, Moormann A, Wilson M, Rochford R . Spatial distribution of Burkitt's lymphoma in Kenya and association with malaria risk. Trop Med Int Health. 2007; 12(8):936-43. DOI: 10.1111/j.1365-3156.2007.01875.x. View

18.

Epstein M, ACHONG B, BARR Y . VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. Lancet. 1964; 1(7335):702-3. DOI: 10.1016/s0140-6736(64)91524-7. View

19.

OCONOR G . Malignant lymphoma in African children. II. A pathological entity. Cancer. 1961; 14:270-83. DOI: 10.1002/1097-0142(196103/04)14:2<270::aid-cncr2820140207>3.0.co;2-q. View

20.

Njie R, Bell A, Jia H, Croom-Carter D, Chaganti S, Hislop A . The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children. J Infect Dis. 2008; 199(1):31-8. DOI: 10.1086/594373. View